ArticleInvestigational new drugs2011

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors.

Joleen Hubbard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.